Low adhesiveness coupled with high superinvasiveness in vitro predicts the in vivo metastatic potential of a mouse mammary adenocarcinoma cell line

Anticancer Research

Volumn 26, Issue 2 A, 2006, Pages 1001-1010

  Glynn, Sharon A ^a   Adams, Aine ^a   Gibson, Brian ^b   Cronin, Deirdre ^c   Harmey, Judith H ^b   Clynes, Martin ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

^b BEAUMONT HOSPITAL   (Ireland)

^c NATIONAL CANCER REGISTRY IRELAND   (Ireland)

Author keywords

Adhesion; Anoikis; Drug resistance; Invasion; Metastasis; Superinvasion

Indexed keywords

ADHESIVE AGENT; ANTIINFECTIVE AGENT; DOXORUBICIN; PACLITAXEL; SCLEROPROTEIN; TAX PROTEIN;

ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BREAST ADENOCARCINOMA; BREAST CELL; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL LINE; TUMOR GROWTH;

ADENOCARCINOMA; ANIMALS; CELL ADHESION; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOTAXIS; DOXORUBICIN; EXTRACELLULAR MATRIX; FEMALE; LUNG NEOPLASMS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; NEOPLASM INVASIVENESS; PACLITAXEL;

EID: 33645810849     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Liang Y, O'Driscoll L, McDonnell S, Doolan P, Oglesby I, Duffy K, O'Connor R and Clynes M: Enhanced in vitro invasiveness and drug resistance with altered gene expression patterns in a human lung carcinoma cell line after pulse selection with anticancer drugs. Int J Cancer 111: 484-493, 2004.
2. Liang Y, McDonnell S and Clynes M: Examining the relationship between cancer invasion/metastasis and drug resistance. Curr Cancer Drug Targets 2: 257-277, 2002.
3. Liang Y, Meleady P, Cleary I, McDonnell S, Connolly L and Clynes M: Selection with melphalan or paclitaxel (Taxol) yields variants with different patterns of multidrug resistance, integrin expression and in vitro invasiveness. Eur J Cancer 37: 1041-1052, 2001.
4. Glynn SA, Gammell P, Heenan M, O'connor R, Liang Y, Keenan J and Clynes M: A new superinvasive in vitro phenotype induced by selection of human breast carcinoma cells with the chemotherapeutic drugs paclitaxel and doxorubicin. Br J Cancer 91: 1800-1807, 2004.
5. Wang F, Cao Y, Liu HY, Xu SF and Han R: Anti-invasion and anti-angiogenesis effect of taxol and camptothecin on melanoma cells. J Asian Nat Prod Res 5: 121-129, 2003.
6. Hegedus B, Zach J, Czirok A, Lovey J and Vicsek T: Irradiation and Taxol treatment result in non-monotonous, dose-dependent changes in the motility of glioblastoma cells. J Neurooncol 67: 147-157, 2004.
7. Seiler N, Schneider Y, Gosse F, Schleiffer R and Raul F: Polyploidisation of metastatic colon carcinoma cells by microtubule and tubulin interacting drugs: effect on proteolytic activity and invasiveness. Int J Oncol 25: 1039-1048, 2004.
8. Kotchetkov R, Cinatl J, Blaheta R, Vogel JU, Karaskova J, Squire J, Hernaiz Driever P, Klingebiel T and Cinatl J Jr: Development of resistance to vincristine and doxorubicin in neuroblastoma alters malignant properties and induces additional karyotype changes: a preclinical model. Int J Cancer 104: 36-43, 2003.
9. Heenan M, O'Driscoll L, Cleary I, Connolly L and Clynes M: Isolation from a human MDR lung cell line of multiple clonal subpopulations which exhibit significantly different drug resistance. Int J Cancer 71: 907-915, 1997.
10. Torimura T, Ueno T, Kin M, Ogata R, Inuzuka S, Sugawara H, Kurotatsu R, Shimada M, Yano H, Kojiro M, Tanikawa K and Sata M: Integrin alpha6beta1 plays a significant role in the attachment of hepatoma cells to laminin. J Hepatol 31: 734-740, 1999.
11. Albini A, Melchiori A, Santi L, Liotta LA, Brown PD and Stetler-Stevenson WG: Tumor cell invasion inhibited by TIMP-2. J Natl Cancer Inst 83: 775-779, 1991.
12. Workman P, Twentyman P, Balkwill F, Balmain A, Chaplin D, Stephens T and Wallace J: United Kingdom Coordinating Committee on Cancer Research (UKCCCR) guidelines for the welfare of animals in experimental neoplasia (Second Edition). Br J Cancer 77: 1-10, 1998.
13. Pulaski BA and Ostrand-Rosenberg S: Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines. Cancer Res 55: 1486-1493, 1998.
14. Yano S, Herbst RS, Shinohara H, Knighton B, Bucana CD, Killion JJ, Wood J and Fidler IJ: Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation. Clin Cancer Res 6: 957-965, 2000.
15. Chambers AF, Groom AC and MacDonald IC: Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2: 563-572, 2000.
16. Luzzi KJ, MacDonald IC, Schmidt EE, Kerkvliet N, Morris VL, Chambers AF and Groom AC: Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 153: 865-873, 1998.
17. Varghese HJ, Davidson MT, MacDonald IC, Wilson SM, Nadkarni KV, Groom AC and Chambers AF: Activated Ras regulates the proliferation/apoptosis balance and early survival of developing micrometastases. Cancer Res 62: 887-891, 2002.
18. Cameron MD, Schmidt EE, Kerkvliet N, Nadkarni KV, Morris VL, Groom AC, Chambers AF and MacDonald IC: Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency. Cancer Res 60: 2541-2546, 2000.
19. Naumov GN, MacDonald IC, Weinmeister PM, Kerkvliet N, Nadkarni KV, Wilson SM, Morris VL, Groom AC and Chambers AF: Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy. Cancer Res 62: 2162-2168, 2002.
20. Evans C (ed.): The Metastatic Cell: Behaviour and Biochemistry. New York: Chapman and Hall, pp. 100, 1991.
21. Lu Z, Ghosh S, Wang Z and Hunter T: Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumour cell invasion. Cancer Cell 4: 499-515, 2003.
22. Bender FC, Reymond MA, Bron C and Quest AF: Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity. Cancer Res 60: 5870-5878, 2000.
23. Ahmad A and Hart IR: Mechanisms of metastasis. Crit Rev Oncol Hematol 26: 163-173, 1997.
24. Valentijn AJ, Zouq N and Gilmore AP: Anoikis. Biochem Soc Trans 32: 421-425, 2004.
25. Ruoslahti E and Reed JC: Anchorage dependence, integrins, and apoptosis. Cell 77: 477-478, 1994.
26. Grossmann J: Molecular mechanisms of detachment-induced apoptosis - anoikis. Apoptosis 7: 247-260, 2002.